SyncThink was granted patent US 14/530,598 by the U.S. Patent and Trade Office, allowing them to use systems and methods for creating and changing dynamic content based on eyegaze analysis. The patent broadens the application of its core technology, especially in the growing arena of virtual reality.

“With this new patent, the EYE-SYNC platform can incorporate tracking and monitoring of the user’s attention to modify content. We believe the potential applications for this patent are wide and significant; from customized content delivery to advertising,” says Founder of SyncThink, Jam Ghajar M.D., Ph.D.

SyncThink plans to use its eye tracking metrics to identify and analyze the attention gaze of the user and will modify the viewing content instantaneously based on the eye analytics. This may be used for training, performance optimization, and understanding how users view and use content in VR most effectively.

This is SyncThink’s 12th granted patent.

Improved catheter delivery

The Streamliner XT, Zeus Industrial Products’ thin-walled polytetrafluoroethylen (PTFE) catheter liner, delivers maximum wall thickness of 0.00075" (0.01905mm). Next in the series, the StreamLiner VT, features a maximum wall thickness of 0.001" (0.025mm) in an ID size range of 0.004" to 0.120" (0.107mm to 3.05mm).

The StreamLiner series makes a sturdier, more robust finished device while retaining torqueablity, pushability, and flexibility. The lubricious StreamLiner XT PTFE liner improves deployment force through the lumen of the catheter for improved minimally-invasive procedures. Sub-Lite-Wall StreamLiner XT and StreamLiner VT allow easier access to small vessels, including peripheral and neurovasculatures.